From major journals, first or last author from the Institute for Cancer Research
Zavaleta E, Solis N, Palacios MI, Zevallos-Escobar LE, Corales EV, Bazo-Alvarez JC, Dominguez-Barrera C, Campos A, Wernhoff P, Ekstrøm PO, Møller P, Visnovska T, Hovig E, Balazar-Palacios J, Alvarez-Valenzuela K, Nakken S, Dominguez-Valentin M(2022) Genetic Characterization in High-Risk Individuals from a Low-Resource City of Peru Cancers (Basel), 14(22) DOI 10.3390/cancers14225603, PubMed 36428697
Huse K, Bai B, Hilden VI, Bollum LK, Våtsveen TK, Munthe LA, Smeland EB, Irish JM, Wälchli S, Myklebust JH(2022) Mechanism of CD79A and CD79B Support for IgM+ B Cell Fitness through B Cell Receptor Surface Expression J Immunol, 209(10), 2042-2053 DOI 10.4049/jimmunol.2200144, PubMed 36426942
Ghiasvand R, Berge LAM, Andreassen BK, Stenehjem JS, Heir T, Karlstad Ø, Juzeniene A, Larsen IK, Green AC, Veierød MB, Robsahm TE(2022) Use of antihypertensive drugs and risk of cutaneous melanoma: a nationwide nested case-control study Int J Epidemiol(in press) DOI 10.1093/ije/dyac223, PubMed 36413027
Ghiasvand R, Berge LAM, Andreassen BK, Stenehjem JS, Heir T, Karlstad Ø, Juzeniene A, Larsen IK, Green AC, Veierød MB, Robsahm TE(2022) Use of antihypertensive drugs and risk of cutaneous melanoma: a nationwide nested case-control study Int J Epidemiol(in press) DOI 10.1093/ije/dyac223, PubMed 36413027
Chen J, Song Y, Li Y, Wei Y, Shen S, Zhao Y, You D, Su L, Bjaanaes MM, Karlsson A, Planck M, Staaf J, Helland Å, Esteller M, Shen H, Christiani DC, Zhang R, Chen F(2022) A trans-omics assessment of gene-gene interaction in early stage NSCLC Mol Oncol(in press) DOI 10.1002/1878-0261.13345, PubMed 36408734
